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eem trees have long been considered the holy grail of holistic and nature-based treatments. The 
medicinal properties that constituents of the trees possess to range from traits that are 
immunomodulatory to traits combat different disease and infections such as anti-inflammatory and 
antibacterial effects, to insulating properties that include cardioprotective and hepatoprotective effects. The role 
of Extended Spectrum Beta-Lactamase positive (ESBL+) bacteria in the occurrence and recurrence of Urinary 
Tract Infection (UTI) infections, particularly in the Gulf region has been studied extensively. However, suggested 
treatment methods have had little success due to a variety of factors which include drug resistance, the inability 
of doctors to calculate the optimal duration for treatment, which has resulted in wrong antibiotic prescriptions, as 
well as lack of understanding of how UTIs work and thrive in different demographics/ populations which again, 
results in inappropriate antibiotic treatment of the disease. These discoveries raised the issue of professionals 
needing better training and education in issues to do with UTIs amongst different demographics of people. In 
this investigation, the medicinal and pharmacological properties of A. indica from neem leaves were assessed 
by studying how they affected the activity of ESBL+ bacteria, based on literature from similar studies. The goal 
and objective of this study were to see if ESBL+ bacteria persisted in the presence of A. Indica from leaf extract, 
as well as gaining an understanding of the factors that affected the persistence and subsequent treatment of the 
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Urinary tract infections (UTIs) are pathogenic diseases 
caused by bacteria traveling up and invading the urinary 
tract, which extends from the urethra to the bladder. UTIs 
are of two types: cystitis and pyelonephritis, with cystitis 
being a lower tract infection confined to the bladder while 
pyelonephritis is an upper tract infection found in the 
ureters and kidneys [1]. 
Colonic bacteria are the most common causes of UTIs, 
which are mostly members of Enterobacteriaceae family 
of different species that have other common traits that 
include being gram-negative, the rod-shaped bacillus 
that are non-fermenting, facultative and anaerobic in 
nature [2]. 
The species' strains that are particularly responsible for 
persistent UTI infections in different population groups 
include Escherichia coli (E. coli) and Klebsiella 
pneumoniae (K. pneumoniae) [1-4]. 
These species strains are responsible for other 
common infections such as bacteremia, infections of the 
central nervous system (CNS), diarrhea as well as 
severe hospital-acquired infections [2]. However, these 
no species types also have strains that can produce 
ESBLs, which can eventually result in antibiotic 
resistance. Studies conducted in the Gulf and Kingdom 
of Saudi Arabian (KSA) states explored the occurrence 
of UTIs in both the pediatric population as well as the 
male and female adult populations and assessed the 
effectiveness of using antibiotics to treat these 
populations. 
Literature by Hanna-Wakim [3], which focused on 
incidence and characteristic features of UTIs in the 
Lebanese pediatric population, found that in a sample of 
675 UTI cases, 77% of those diagnosed were girls. 
Hanna-Wakim [3] also noted an increasing resistance to 
cephalosporins and fluoroquinolones by ESBL-
producing organisms that were noted to cause the UTIs. 
In another study on the pediatric population in Jordan by 
Al-Momani [5], the majority of cases were identified in the 
age group of 1-5-year-olds and the infections were 
caused by different species types which were suggested 
to require different dosage adjustments and/or different 
methods of treatments. In Qatar, Eltai [6] discovered that 
dominance by ESBL-producing E. coli and K. 
pneumoniae gave rise to the need for regulating UTI 
treatment in children. 
According to Alshalat's [7] he targeted on older adults 
in Qatar revealed that the incidence of UTIs and 
Catheter-associated UTIs (CA-UTIs), in homecare was 
especially high, with 132 individuals out of the total 
sample of 614, being diagnosed with a UTI within the 
period of the study, which was revealed to be caused by 
E. coli. Literature by Al Salman [8] showed how 
inappropriate antibiotic treatment was common in 
treatments prescribed by ER doctors and how males 
were prone to receiving these wrong types of treatments 
because doctors failed to adjust treatment's optimal 
duration.  
All these cases in the literature where wrongful 
antibiotic treatment was prescribed, made it apparent 
that there is a need to explore alternative avenues in 
treating UTIs in both pediatric and adult populations. This 
has led to the study of the Neem tree and its medicinal 
properties which produce effects that range from being 
anti-inflammatory, to immunomodulatory, to antifungal 
and antibacterial in nature [9,10]. 
Methods 
Literature Search and Selection Criteria: The study 
was conducted in Saudi Arabia and Gulf countries. The 
literature search strategy was done in an orderly and 
methodical way in Saudi digital library (SDL), Web of 
Science and PubMed medical databases as they are 
more frequently used in these Gulf countries. This was 
to identify publications within the last two decades that 
are relevant to the review. The search strategy took in all 
articles encompassing the descriptors, and their 
structures were advanced in reference to the jargon 
terms of each database that focused on the abstract and 
title. The search was conducted on the basis of 
identifying Gram-negative associated infections and 
Enterobacteriaceae producing infections. The study was 
conducted across all age groups. More articles and 
publications were found in the citations of the former, 
already identified articles. To be able to locate the 
associated publications, certain criteria were used. For 
the criteria, research must have accounted for one 
pathogenic bacteria genus among the Gram-negative 
bacteria, must have been conducted with human as 
subjects of the tests, should have been able to pinpoint 
bacteria and identify it from the available specimen, and 
must have been conducted in Saudi Arabia and the Gulf 
countries and published in English. Consequently, 
articles and publications that were not conducted in 
Saudi Arabia and the Gulf countries, and/or those ones 
that did not focus on any of the criteria used, were 
exempted. The selection of publications, therefore, was 
done according to the relevance of titles of the articles of 
the identified literature and their state on the basis of the 
inclusion criteria. Contents that matched the inclusion 
criteria and had been conducted in Saudi Arabia and Gulf 
countries and had been published in English were 
assessed and used for this review. 
Discussion 
Resistant ESBL+ K. pneumoniae infected Urothelial 
cells and the subsequent UTI 
ESBL+ bacteria are bacteria that produce enzymes 
capable of hydrolyzing penicillin, broad-spectrum 
cephalosporins and monobactams [11].  These ESBLs 
are often located on strains that are transferrable from 
strain to strain and between species [2,11]. E. coli and K. 
pneumoniae account for 10-40% of ESBL-producing 
bacteria that pose resistance to the beta-lactam 
antibiotics that are normally used to treat them [2]. 
Beta-lactam antibiotics are produced from a wide 
range of antimicrobial agents, according to literature by 
Sah [2]. consisting of a 4-atom ring called the beta-
lactam ring, within their structure. It is this beta-lactam 
ring that prevents cell wall synthesis in bacteria, thereby 
inhibiting their growth. Antibiotics common to this group 
include penicillin and cephalosporins such as 
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cefotaxime, ceftazidime, monobactams, imipenem and 
oxymino-monobactam. 
ESBL+ bacteria hydrolyze the 4-ring beta-lactam ring 
thereby inactivating it and making it easier for their 
survival as shown below:  
 
Figure 1: Inactivation of cephalosporin through hydrolysis of beta-
lactam Ring by an ESBL [2]. 
ESBL+ bacteria tend to fall in one of three classes 
which are: TEM (Temorina Escherichia coli mutant), SHV 
(Sulfhydryl variant), and CTX-M (Cefotaximase-Munich) 
types, with ESBL+ K. pneumoniae strains being 
predominantly in the SHV-1 group, while most ESBL+ E. 
coli strains falling in the TEM group [2,11]. 
ESBL+ K. pneumoniae in particular is a resilient 
bacterium that has been noted to cause uncomplicated, 
complicated and recurrent UTIs. In uncomplicated cases 
of tract infections, symptoms are typically presented in 
women who are not pregnant, and the symptoms are 
localized to the lower urinary tract and are either of a 
dysuria or frequency or urgency nature [4,12]. 
Complicated cases of UTI caused by ESBL+ K. 
pneumoniae include complicated pyelonephritis, with 
42.8% of cases in North America and Europe being 
linked to ESBL+ K. pneumoniae [4]. It persists in 
complicated pyelonephritis because continued antibiotic 
treatment with antibiotics such as ciprofloxacin in its mild 
stages, eventually makes the pathogen resistant to 
carbapenem through its synthesis of carbapenemase 
This in turn, makes it resistant to almost every beta 
lactam-based antibiotic available [4,12]. 
Azadirachta indica (Neem): The benefit of the Neem 
plant on UTI and other infections 
Neem trees have attracted world prominence as holy 
trees with unique medicinal properties that include 
immunomodulatory effects, anticancerous effects, 
hepatoprotective effects amongst others as shown 
below: 
 
Figure 2: Neem’s pharmacological activities [13]. 
It is an evergreen tree that grows 15-20 meters in 
length and belongs to the Meliaceae family that grows in 
the tropical parts of the globe such as Asia, Africa as well 
as in the Indian subcontinent and, has an average 
lifespan of 150-300 years [9,10]. 
Structurally, neem presents an elaborate array of 
phytochemicals that are biologically active, chemically 
diverse and structurally variable, with over 140 
compounds that can be isolated from different parts of 
the tree [9]. Of interest are the neem leaves which have 
been linked to most of the medicinal properties 
associated with the tree. Over 60 chemically active 
compounds that are chemically accounted for have been 
identified, these are listed in Table1 and Figure 3 [10].  
Compound Name Formula Compound Name Formula 
Azadirachtin C35H44O16 Nimbocinone C30H46O4 
Ascorbic acid C6H8O6 Nimbolide C27H30O7 
Chlorogenic acid C16H18O9 Nimocin C6H5NO2 
Hyperoside C21H20O12 Nimocinol C28H36O5 
Kaempferol C15H10O6 Nimocinolide C28H36O7 
Kaempferol-3-o-
rutinoside 




Nimbafalavone C26H30O5 Rutin C27H30O16 
Nimbandiol C26H32O7 Scopoletin C10H8O4 
Nimbin C30H36O9 Stigmasterol C29H48O 
Nimbin,6-deacetyl C28H34O8 Valasinin C26H36O5 
Nimbinene C28H34O7 Zafaral C29H40O6 
Nimbocinolide C32H42O10   
Table 1: Leaf components by Yadav [10]. 
 
Figure 3: The major chemical compounds of neem leaf.  [The name 
and structure of various compounds were described in the table above 
[10]. 
Compounds such as azadirachtin, chlorogenic acid, 
quercetin, kaempferol/derivatives, myricetin, nimbin, 
nimbolide, scopoletin and sigmasterol/β-Sitosterol have 
been shown to possess antioxidant and anti-
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inflammatory properties, with rutin, being proven to have 
antihyperglycemic properties as well [10].  Because of 
this, neem leaves have been used to treat acne, eczema, 
and other dermatophytic infections successfully [14]. 
Literature by Yadav [10] has cited links between 
compounds like azadirachtin to the leaf’s anticancerous 
properties, with compounds such as Nimbolide being 
shown to suppress tumor growth by inhibiting cell viability 
through the induction of programmed cell death 
(apoptosis). The hepatoprotection of neem leaves was 
demonstrated through rats, whereby anti-tubercular 
drug-induced damage was reduced by minimizing 
alteration of bilirubin, alanine aminotransferase, 
aspartate aminotransferase, and alkaline phosphatase in 
vitro serums. In Yadav's [10], study, antimicrobial, 
antiviral and antibacterial properties had not yet fully 
been explored, to explain which compounds were 
responsible for these effects.  
Treatment of ESBL-Positive E. coli and K. 
pneumoniae using Azadirachta indica (Neem) 
The antifungal and antibacterial properties of neem 
leaves seem to be linked to their antioxidant and anti-
inflammatory effects, which in turn, affect bacterial cell 
processes and inhibit cell growth [10,14]. 
A study by Mistry [15] revealed that neem extract was 
active against S. mutans, E. faecalis, and S. aureus. The 
leaves’ extract was also found to be effective for 
inhibiting the growth of P. aeruginosa, S. aureus, and 
Bacillus pumilus, and the effect was compatible with that 
of antibiotics [16]. A similar study conducted by 
Parashar, Sutar, and Sanap [17] showed that the optimal 
effect on E. coli, S. aureus, P. aeruginosa and Bacillus 
subtilis can be achieved by combining the neem extract 
with lantana (Lantana Camara) extract made from the 
plants’ leaves.  
Research shows that neem is active against both 
gram-positive and gram-negative bacteria. A study by 
Rathod [18] examined the effects of ethanol and 
aqueous extracts of neem leaves and bark on B. subtilis, 
S. aureus, K. pneumoniae, and E. coli. It has been found 
that neem bark was the most effective against the listed 
bacteria. However, the use of the low concentrations was 
found to be ineffective as bacteria were resistant to them. 
Thus, Rathod [18] proved the potential usefulness of 
neem for primary health care, as it can become an 
effective alternative to antibiotics. Francine [19] also 
discussed the importance of extract concentration. The 
researchers found that the higher the concentration of 
the extract is, the greater the inhibition zone. In addition, 
they proved the superiority of fresh leaves and bark over 
dried parts. Ethanol extracts, in turn, were found to be 
more effective than aqueous [19]. 
Along similar lines, Mamman [20] argued that 
concentration matters when it comes to achieving a 
significant antibacterial effect. The scholars conducted a 
study exploring the effects of neem on E. coli, Salmonella 
spp, and S. aureus. Results have demonstrated that a 
minimum concentration of 43.75 mg/ml inhibited the 
growth of E. coli for both the aqueous and methanolic 
extracts. However, a higher concentration (87.50 mg/ml) 
was needed to kill the bacteria altogether. To kill E. coli 
using a methanolic extract, the researchers had to 
increase the time of exposure and extract concentration 
(250 mg/ml) [20]. Banna, Parveen, and Iqbal [21], in turn, 
found that at the concentration of 12.5 mg/mL, ethanolic 
extract of neem leaves has an inhibitory effect on K. 
pneumoniae. In this way, both Mamman [20] and Banna 
[21] vividly demonstrated the importance of measuring 
the right dosages, concentration, and type of extract to 
achieve the optimal results.  
Recommendations and Future plans: 
While neem leaves have shown tremendous therapeutic 
and medicinal potential, the unfortunate part is research 
on the effects of neem on antibiotic-resistant bacteria is 
scarce. Nayim [21] who explored the effects of plants on 
gram-negative resistant bacteria, including E. coli and K. 
pneumoniae, conducted one of the studies on the topic.  
Interestingly, it has been found that bark extract of 
neem improved the antibacterial activities of such 
antibiotics like tetracycline, chloramphenicol, kanamycin, 
streptomycin, and others. In this way, one may suggest 
that the combination of commonly used antibiotics with 
neem extracts can be effective for treating infections 
caused by multidrug-resistant bacteria. Given the 
knowledge gap, more research is needed to explore 
whether neem could be used against ESBL-producing E. 
coli and K. pneumoniae.  
Secondly, based on the case studies explored in this 
study, age and gender appear to be factors that play a 
part in the persistence of ESBL+ bacteria in causing 
UTIs. This needs to be explored more, particularly in 
relation to how optimal dosages can be achieved in 
antibiotic treatments for different age and gender 
demographics, as this will also become a guideline on 
how to accurately produce neem extracts with the right 
concentration needed to treat bacterial infections.  
Thirdly, research should focus on the mechanisms by 
which neem antimicrobial/ antibacterial/ antifungal 
potential works in disrupting bacterial and/or microbial 
cell growth. Because of knowledge gaps in how these 
properties are achieved, it then becomes difficult to 
understand what optimum dosages can be used and 
what other factors can influence or retard the medicinal 
properties of neem leaves. 
Conclusion 
The bean tree has upheld its medicinal prominence for 
decades, particularly in populations that the tree is 
indigenous. Indians have used the leaves' extract to heal 
wounds, eliminate effects of bacterial and fungal 
infections as well as reduce toxicity in the body. The 
focus of this particular study was to assess how neem 
leaf extracts affect ESBL+ bacteria that cause bacteria 
and while, results gathered from other studies reflected 
a positive outcome, the knowledge gaps on mechanisms 
and reactivity to antibiotic-resistant bacteria makes it 
difficult to fully endorse the use of neem leaf extract as a 
stand-alone alternative to antibiotic treatment of UTIs. 
The need for more research that focuses on the influence 
of factors such as age and gender and how they relate 
to the resistance of ESBL+ bacteria is apparent. 
Furthermore, the need for exploring how these factors 
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play a part in determining treatment alternatives is key. 
However, from this study alone, there is enough 
evidence to expect an eye-opening outcome from the 
suggested future investigations. But until then, neem leaf 
extract must continue to be considered as a viable 
treatment option for bacterial infections. 
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